Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 1.8 to 1.
-
Busy address KBO
58 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Ascensus Specialties from Brussel, company number BE0700966342, closed financial year 2025 with a result of € 379,719 after tax. For that financial year Ascensus Specialties recorded revenue of € 10.8 million and equity of € 1.9 million. Compared with financial year 2024, the result moved from € -24,893 to € 379,719. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ 1.9 million
▲ 33% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 379,719
▲ still € 24,893 loss in 2024
Profit after tax over the fiscal year.
€ 85,967
▼ 55% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.9 million.
People and assets in 2025
1
▼ 0.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 382,652
▼ 45% vs 2024
€ 382,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 10.2 million
▲ 43% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 100,457
▼ 16% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 14,841,045 | € 9,250,071 | € 11,020,062 | € 10,764,455 | ▼ 2% |
| Gross margin | - | - | € 941,362 | € 813,578 | ▼ 14% |
| Profit after taxes | € 423,915 | € 250,112 | € -24,893 | € 379,719 | ▲ € 404,613 |
| Equity | € 1,196,226 | € 1,446,338 | € 1,421,444 | € 1,892,518 | ▲ 33% |
| Total debts | € 3,731,375 | € 760,043 | € 7,303,046 | € 10,645,493 | ▲ 46% |
| Cash | € 822,894 | € 112,386 | € 191,825 | € 85,967 | ▼ 55% |
| Retained profit | € 1,177,676 | € 1,427,788 | € 1,402,894 | € 1,873,968 | ▲ 34% |
| Balance sheet total | € 4,927,601 | € 2,206,381 | € 8,724,491 | € 12,538,011 | ▲ 44% |
| Employees (FTE) | 2.3 | 1.8 | 1.6 | 1 | ▼ 0.6 |
Key figures of Ascensus Specialties, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Ascensus Specialties?
What happened at Ascensus Specialties in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 379,719. Source: NBB ↗
- John Robella became a director. NBB
- Mario Sandoval became a director. NBB
- Paul Burlingame became a director. NBB
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 423,915 profit in 2022 to € 379,719 profit in 2025.
Paid € 408,792 in corporate taxes since 2022.
Best year ever: 2022, with € 423,915 profit.
On average € 813,600 of value added per employee in 2025.
A new publication or filing at Ascensus Specialties? We notify you, reason included.
Follow Ascensus SpecialtiesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Ascensus Specialties are John Robella, Mario Sandoval and Paul Burlingame.
Directors
According to the 2025 annual accounts
John Robella
Director
since 2025
Mario Sandoval
Director
since 2024
Paul Burlingame
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Marnixlaan 23
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 58 companies are registered at this address.
All companies at this address →TELEFLEX MEDICAL
€ 18.7 million revenue · 2025
CUSHMAN & WAKEFIELD WINSSINGER TIE LEUNG
€ 218,925 revenue · 2024
Paardekooper België
Sunparks Oostduinkerke
€ 3.9 million revenue · 2025
CUSHMAN & WAKEFIELD BELGIUM
€ 14.4 million revenue · 2024
+53 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0700.966.342
- VAT number
- BE 0700.966.342
- Registered office
- Marnixlaan 23, 1000 Brussel
- Names & denominations
- Ascensus Specialties
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 August 2018
- Peppol
- Active · Active since 9 Mar 2026
- Activities · NACE
Vervaardiging van andere chemische producten, neg
Groothandel in chemische producten voor industrieel gebruik